title: Assisted ventilation in neonates: the Manipal experience.
abstract: Case records of 68 newborns who required assisted ventilation over a 24 month period were reviewed. Fortyfour (64.7%) received intermittent mandatory ventilation, 10 (14.7%) received nasal CPAP and the remaining 14 (20.58%) received a combination of the above. Some of the indications for ventilation were infections (21), hyaline membrane disease (16), problems related to asphyxia (11), apnea of prematurity (10) and persistent pulmonary hypertension of newborn (5). The overall survival rate was 41.17%. In the CPAP group 90% (9/10) survived, while in the remaining survival was 32.7% (19/58). The best outcome was observed in persistent pulmonary hypertension of newborn (80%) followed by apnea of prematurity (70%) and hyaline membrane disease (43.75). Outcome was poor in conditions related to birth asphyxia (27.2%) and infections (19.05%). Survival rates were higher (44.4%) in babies weighing > 1500g at birth as compared to 40.9% in babies < 1500g. Babies less than 32 weeks gestation had a survival rate of 32% as compared to 46.5% in those over 32 weeks. This difference was not statistically significant. Complications were seen in 12/68 patients (17.6%). Pneumothorax was the commonest followed by sepsis, intraventricular hemorrhage and blocked endotracheal tubes. Babies with hyaline membrane disease had the highest incidence of complications. Analysis of the data with regard to the indications, outcome and complications is presented.
authors.affiliation: Department of Pediatrics, Kasturba Medical College and Hospital, Manipur.
authors.forename: L
authors.initials: L
authors.lastname: Krishnan
authors.forename: P P
authors.initials: PP
authors.lastname: Francis
authors.forename: N A
authors.initials: NA
authors.lastname: D'Souza
authors.forename: N
authors.initials: N
authors.lastname: Bhaskaranand
mesh_terms: D001049:Apnea / Q000453:epidemiology; D001238:Asphyxia Neonatorum / Q000453:epidemiology; D001424:Bacterial Infections / Q000453:epidemiology / Q000209:etiology; D002543:Cerebral Hemorrhage / Q000209:etiology; D006801:Humans; D006819:Hyaline Membrane Disease / Q000453:epidemiology; D015994:Incidence; D007194:India / Q000453:epidemiology; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000453:epidemiology; D007385:Intermittent Positive-Pressure Ventilation / Q000009:adverse effects / Q000706:statistics & numerical data; D007442:Intubation, Intratracheal; D010547:Persistent Fetal Circulation Syndrome / Q000453:epidemiology; D011030:Pneumothorax / Q000209:etiology; D011175:Positive-Pressure Respiration / Q000009:adverse effects / Q000706:statistics & numerical data; D012121:Respiration, Artificial / Q000009:adverse effects / Q000706:statistics & numerical data*; D015996:Survival Rate; D016896:Treatment Outcome